1A8M | A:6-157; B:6-157; C:6-157 | TUMOR NECROSIS FACTOR ALPHA, R31D MUTANT |
1ALY | A:116-261 | CRYSTAL STRUCTURE OF HUMAN CD40 LIGAND |
1D0G | A:119-281; B:119-281; D:119-281 | CRYSTAL STRUCTURE OF DEATH RECEPTOR 5 (DR5) BOUND TO APO2L/TRAIL |
1D2Q | A:121-281; B:121-281 | CRYSTAL STRUCTURE OF HUMAN TRAIL |
1D4V | B:119-281 | CRYSTAL STRUCTURE OF TRAIL-DR5 COMPLEX |
1DG6 | A:120-281 | CRYSTAL STRUCTURE OF APO2L/TRAIL |
1DU3 | D:120-281; E:120-281; F:120-281; J:120-281; K:120-281; L:120-281 | CRYSTAL STRUCTURE OF TRAIL-SDR5 |
1GR3 | A:549-680 | STRUCTURE OF THE HUMAN COLLAGEN X NC1 TRIMER |
1I9R | A:119-261; B:119-261; C:119-261 | STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY |
1JH5 | A:1-144; B:1-144; C:1-144; D:1-144; E:1-144; F:1-144; G:1-144; H:1-144; I:1-144; J:1-144 | CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND |
1KD7 | A:142-285; B:142-285; C:142-285; K:142-285; L:142-285; M:142-285 | CRYSTAL STRUCTURE OF AN EXTRACELLULAR DOMAIN FRAGMENT OF HUMAN BAFF |
1KXG | A:142-285; B:142-285; C:142-285; D:142-285; E:142-285; F:142-285 | THE 2.0 ANG RESOLUTION STRUCTURE OF BLYS, B LYMPHOCYTE STIMULATOR. |
1OQD | A:1-144; F:1-144; G:1-144; H:1-144; I:1-144; J:1-144; B:1-144; C:1-144; D:1-144; E:1-144 | CRYSTAL STRUCTURE OF STALL-1 AND BCMA |
1OQE | A:1-144; B:1-144; C:1-144; D:1-144; E:1-144; F:1-144; G:1-144; H:1-144; I:1-144; J:1-144 | CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R |
1OSG | A:142-285; B:142-285; C:142-285; D:142-285; E:142-285; F:142-285 | COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD |
1PK6 | A:90-222; B:92-223; C:89-217 | GLOBULAR HEAD OF THE COMPLEMENT SYSTEM PROTEIN C1Q |
1RJ7 | H:247-388; I:247-389; J:248-390; A:247-390; B:247-390; D:247-390; F:247-390; G:247-390; M:247-390; K:247-391; L:246-390; E:242-390 | CRYSTAL STRUCTURE OF EDA-A1 |
1RJ8 | A:248-389; B:248-389; D:248-389; E:248-389; F:248-389; G:248-389 | THE CRYSTAL STRUCTURE OF TNF FAMILY MEMBER EDA-A2 |
1TNF | A:6-157; B:6-157; C:6-157 | THE STRUCTURE OF TUMOR NECROSIS FACTOR-ALPHA AT 2.6 ANGSTROMS RESOLUTION. IMPLICATIONS FOR RECEPTOR BINDING |
1TNR | A:28-171 | CRYSTAL STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX: IMPLICATIONS FOR TNF RECEPTOR ACTIVATION |
2AZ5 | D:10-157; B:10-157; A:10-157; C:10-157 | CRYSTAL STRUCTURE OF TNF-ALPHA WITH A SMALL MOLECULE INHIBITOR |
2E7A | B:8-157; C:8-157; A:8-157 | TNF RECEPTOR SUBTYPE ONE-SELECTIVE TNF MUTANT WITH ANTAGONISTIC ACTIVITY |
2JG8 | A:90-222; B:91-224; E:92-224; C:87-217; F:89-217; D:90-222 | CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS COMPLEXED TO PHOSPHATIDYL-SERINE |
2JG9 | A:90-223; B:92-224; E:92-224; C:89-217; F:89-217; D:90-223 | CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS (P1) |
2Q1M | A:57-172 | CRYSTAL STRUCTURE OF HUMAN GITRL |
2R30 | A:57-172 | CRYSTAL STRUCTURE OF HUMAN GITRL MUTANT |
2TUN | A:7-157; B:7-157; C:7-157; D:7-157; E:7-157; F:7-157 | CONFORMATIONAL CHANGES IN THE (ALA-84-VAL) MUTANT OF TUMOR NECROSIS FACTOR |
2WNU | A:90-222; B:92-224; E:92-224; C:89-217; F:89-217; D:90-222 | COMPLEX BETWEEN C1Q GLOBULAR HEADS AND HEPARAN SULFATE |
2WNV | D:90-223; A:90-223; E:93-224; C:89-217; F:89-217; B:92-224 | COMPLEX BETWEEN C1Q GLOBULAR HEADS AND DEOXYRIBOSE |
2ZJC | A:8-157; C:8-157; B:7-157 | TNFR1 SELECTVE TNF MUTANT; R1-6 |
2ZPX | A:8-157; B:8-157; C:8-157 | TNF RECEPTOR SUBTYPE ONE-SELECTIVE TNF MUTANT WITH ANTAGONISTIC ACTIVITY; R1ANTTNF-T8 |
3B93 | A:55-177; B:57-177; C:57-176 | CRYSTAL STRUCTURE OF HUMAN GITRL |
3B94 | B:57-175; D:56-175; A:56-175; C:57-176 | CRYSTAL STRUCTURE OF HUMAN GITRL |
3IT8 | A:6-157; B:6-157; C:6-157; G:6-157; H:6-157; I:6-157 | CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN |
3L9J | T:9-157 | SELECTION OF A NOVEL HIGHLY SPECIFIC TNFALPHA ANTAGONIST: INSIGHT FROM THE CRYSTAL STRUCTURE OF THE ANTAGONIST-TNFALPHA COMPLEX |
4TSV | A:10-157 | HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT |
5TSW | A:9-157; B:9-157; C:9-157; D:9-157; E:9-157; F:9-157 | HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT |